Connexin and pannexin (hemi)channels: emerging targets in the treatment of liver disease (2019)
Source: Hepatology. Unidade: FMVZ
Subjects: CONEXINAS, HEPATOPATIAS, JUNÇÕES INTERCELULARES
ABNT
COOREMAN, Axelle et al. Connexin and pannexin (hemi)channels: emerging targets in the treatment of liver disease. Hepatology, v. 69, n. 3, p. 1317-1323, 2019Tradução . . Disponível em: https://doi.org/10.1002/hep.30306. Acesso em: 17 ago. 2024.APA
Cooreman, A., Van Campenhout, R., Ballet, S., Annaert, P., Van Den Bossche, B., Colle, I., et al. (2019). Connexin and pannexin (hemi)channels: emerging targets in the treatment of liver disease. Hepatology, 69( 3), 1317-1323. doi:10.1002/hep.30306NLM
Cooreman A, Van Campenhout R, Ballet S, Annaert P, Van Den Bossche B, Colle I, Cogliati B, Vinken M. Connexin and pannexin (hemi)channels: emerging targets in the treatment of liver disease [Internet]. Hepatology. 2019 ; 69( 3): 1317-1323.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1002/hep.30306Vancouver
Cooreman A, Van Campenhout R, Ballet S, Annaert P, Van Den Bossche B, Colle I, Cogliati B, Vinken M. Connexin and pannexin (hemi)channels: emerging targets in the treatment of liver disease [Internet]. Hepatology. 2019 ; 69( 3): 1317-1323.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1002/hep.30306